Unknown

Dataset Information

Development and validation of a prognostic model for leflunomide discontinuation with abnormal blood tests during long-term treatment: cohort study using data from the Clinical Practice Research Datalink Gold and Aurum.


ABSTRACT:

Objective

To develop and validate a prognostic model for LEF discontinuation with abnormal blood test results.

Methods

Data from the Clinical Practice Research Datalink Gold and Aurum were used for model development and external validation, respectively. Participants prescribed LEF between 1 January 2007 and 31 December 2019 were followed up from 6 months after the first general practitioner prescription to the earliest of date of outcome, death, 5 year follow-up or 31 December 2019. Candidate prognostic factors were ascertained using theory and data-driven approaches. Penalized Cox regression was performed to develop the risk equation, followed by internal validation using 500 bootstraps to correct for optimism. Multiple imputation was applied to handle missing data. Model

SUBMITTER: Nakafero G 

PROVIDER: S-EPMC9258529 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature